Skip to Main Content

An official website of the United States government

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Name Principal Investigator Institution Study Date Approved Project ID
Genetic determinants of liver cancer Sonja Berndt National Cancer Institute PLCO Feb 5, 2024 PLCO-1467
Development and Validation of Early Detection Biomarkers for Liver Cancer Xuehong Zhang Yale University PLCO Jan 30, 2024 2023-0085
Spatial Interplay of Tumor-Infiltrating Lymphocytes and Cancer Cells Identify Low-Risk Patients with Favorable Prognosis across Multiple Gastrointestinal Cancers Anant Madabhushi Emory University PLCO Jan 30, 2024 PLCOI-1468
Microsimulation model of a risk-based lung cancer screening program Jacopo Di Silvestre University of Oslo NLST Jan 26, 2024 NLST-1191
Early Detection and Personalized Treatment of Colon Cancer: Integrating Genetic, Demographic, and Lifestyle Data JULIET KURUVILLA HOWARD UNIVERSITY PLCO Jan 26, 2024 PLCO-1460
A study using AI methods to examine the effects of malnutrition on cancer patients' life expectancies Shaesta Mujawar P. G. Department of Computer Science, S.N.D.T. Women's University PLCO Jan 26, 2024 PLCO-1455
Evolution of cancer stage and mortality in the PLCO trial (NCI Version) Eric Miller NCI PLCO Jan 22, 2024 PLCO-1462
Time course of biomarkers Paul Pinsky DCP, NCI PLCO Jan 18, 2024 PLCO-1454
Lung disease detection using CT scan and AI Vaibhav Ram SRM institute of science and technology NLST Jan 17, 2024 NLST-1190
Predicting Prostate cancer Tissue type with machine learning Md. Salman Karim Khan Chittagong Medical College PLCO Jan 17, 2024 PLCO-1450
Lung Cancer Risk Analysis Danbir Rashid Leading University NLST Jan 16, 2024 NLST-1187
Lung Cancer Risk Analysis Danbir Rashid Leading University PLCO Jan 16, 2024 PLCO-1447
Ovarian Cancer Classification Lakshmi kumari Puducherry Technological University PLCO Jan 16, 2024 PLCO-1443
Cancer risk assessment by GAGome - a noninvasive biomarker for risk-stratified multi-cancer early detection Volker Liebenberg Elypta AB PLCO Jan 16, 2024 2023-0081
The Practical Application of the Lung Cancer Risk Prediction Model 'Sybil': Replicating and Validating Study Results in Taiwan Tsung-Ren Huang National Taiwan University NLST Jan 11, 2024 NLST-1186
A Deep Learning Approach for Prostate Cancer Screening Julio Cesar Gali Pontifícia Universidade Católica de São Paulo PLCO Jan 11, 2024 PLCO-1440
Validation of proteomic assay for early detection of pancreatic cancer using PLCO pre-diagnostic specimens Ru Chen Baylor College of Medicine PLCO Jan 11, 2024 2023-0088
AI-based prognosis and therapy response prediction from pathology images Iurii Tolkach Institute of Pathology, University Hospital Cologne PLCO Jan 9, 2024 PLCOI-1441
Pan-cancer digital pathology AI foundation model and its application in cancer prognostication Jan Witowski Ataraxis AI, Inc. PLCO Jan 9, 2024 PLCOI-1433
Risk prediction of prostate cancer mortality in a screening cohort. Patrick Lewicki University of Michigan PLCO Jan 9, 2024 PLCO-1439